BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 22647358)

  • 1. Cross talk between microRNA and coding cancer genes.
    Kunej T; Godnic I; Horvat S; Zorc M; Calin GA
    Cancer J; 2012; 18(3):223-31. PubMed ID: 22647358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNAs as oncogenes and tumor suppressors.
    Zhang B; Pan X; Cobb GP; Anderson TA
    Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-nucleotide polymorphisms among microRNA: big effects on cancer.
    Song FJ; Chen KX
    Chin J Cancer; 2011 Jun; 30(6):381-91. PubMed ID: 21627860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.
    Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes.
    Calin GA; Croce CM
    Blood; 2009 Nov; 114(23):4761-70. PubMed ID: 19745066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Mechanisms of MicroRNA Downregulation in Cancer.
    Williams M; Cheng YY; Blenkiron C; Reid G
    Microrna; 2017; 6(1):2-16. PubMed ID: 27928946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA genetic alterations in human cancers.
    Giannakakis A; Coukos G; Hatzigeorgiou A; Sandaltzopoulos R; Zhang L
    Expert Opin Biol Ther; 2007 Sep; 7(9):1375-86. PubMed ID: 17727327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of microRNA Binding Site Distribution and microRNA-Mediated Gene Expression Repression of Oncogenes and Tumor Suppressor Genes.
    Tian S; Wang J; Zhang F; Wang D
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA function in cancer: oncogene or a tumor suppressor?
    Shenouda SK; Alahari SK
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Dysregulated MicroRNA Expression in Lung Cancer.
    Krutakova M; Sarlinova M; Matakova T; Dzian A; Hamzik J; Pec M; Javorkova S; Halasova E
    Adv Exp Med Biol; 2016; 911():1-8. PubMed ID: 26987328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA in carcinogenesis & cancer diagnostics: a new paradigm.
    Ahmad J; Hasnain SE; Siddiqui MA; Ahamed M; Musarrat J; Al-Khedhairy AA
    Indian J Med Res; 2013 Apr; 137(4):680-94. PubMed ID: 23703335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA dysregulation in gastric cancer: a new player enters the game.
    Wu WK; Lee CW; Cho CH; Fan D; Wu K; Yu J; Sung JJ
    Oncogene; 2010 Oct; 29(43):5761-71. PubMed ID: 20802530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-143 as a new weapon against cancer: overview of the mechanistic insights and long non-coding RNA mediated regulation of miRNA-143 in different cancers.
    Farooqi AA; Qureshi MZ; Attar R; Alhewairini SS; Fayyaz S; Sabitaliyevich UY; Duisenbayevich TM; Alaaeddine N
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):1-5. PubMed ID: 31472055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-452: a double-edged sword in multiple human cancers.
    Karimi Dermani F; Datta I; Gholamzadeh Khoei S
    Clin Transl Oncol; 2023 May; 25(5):1189-1206. PubMed ID: 36622551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.
    Manikandan M; Munirajan AK
    OMICS; 2014 Feb; 18(2):142-54. PubMed ID: 24286505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs: Master regulators as potential therapeutics in cancer.
    Garofalo M; Croce CM
    Annu Rev Pharmacol Toxicol; 2011; 51():25-43. PubMed ID: 20809797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant regulation and function of microRNAs in cancer.
    Adams BD; Kasinski AL; Slack FJ
    Curr Biol; 2014 Aug; 24(16):R762-76. PubMed ID: 25137592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Disease-miRNA Networks Across Different Cancer Types Using SWIM.
    Fiscon G; Conte F; Farina L; Pellegrini M; Russo F; Paci P
    Methods Mol Biol; 2019; 1970():169-181. PubMed ID: 30963493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.